Fuji Pharma Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3816200004
JPY
2,151.00
-125 (-5.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
13,819.00
15,897.00
14,723.00
12,859.00
11,095.00
13,000.00
12,983.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
13,819.00
15,897.00
14,723.00
12,859.00
11,095.00
13,000.00
12,983.00
Raw Material Cost
8,304.00
9,078.00
8,712.00
7,997.00
6,510.00
7,785.00
7,737.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
105.00
84.00
93.00
95.00
66.00
76.00
59.00
Selling and Distribution Expenses
3,215.00
3,211.00
3,154.00
3,054.00
2,915.00
3,216.00
2,681.00
Other Expenses
58.30
73.70
114.10
65.20
55.20
66.90
84.20
Total Expenditure (Excl Depreciation)
12,207.00
13,110.00
13,100.00
11,798.00
10,043.00
11,746.00
11,319.00
Operating Profit (PBDIT) excl Other Income
1612
2787
1623
1061
1052
1254
1664
Other Income
70.00
-5.00
21.00
-24.00
34.00
48.00
4.00
Operating Profit (PBDIT)
2,734.00
3,785.00
2,653.00
2,003.00
2,065.00
2,313.00
2,654.00
Interest
105.00
84.00
93.00
95.00
66.00
76.00
59.00
Exceptional Items
-1,089.00
-2,501.00
-250.00
6.00
-640.00
147.00
-155.00
Gross Profit (PBDT)
5,515.00
6,819.00
6,011.00
4,862.00
4,585.00
5,215.00
5,246.00
Depreciation
1,052.00
1,003.00
1,009.00
966.00
979.00
1,011.00
986.00
Profit Before Tax
487.00
196.00
1,301.00
948.00
379.00
1,372.00
1,457.00
Tax
99.00
-128.00
132.00
404.00
83.00
381.00
219.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
389.00
324.00
1,170.00
543.00
296.00
991.00
1,237.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
389.00
324.00
1,170.00
543.00
296.00
991.00
1,237.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
389.00
324.00
1,170.00
543.00
296.00
991.00
1,237.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
51,359.00
47,948.00
46,905.00
45,524.00
45,731.00
47,756.00
45,560.00
Earnings per share (EPS)
15.5
13.25
47.84
22.23
12.12
40.74
50.84
Diluted Earnings per share
15.5
13.25
47.84
22.23
12.12
40.74
50.84
Operating Profit Margin (Excl OI)
11.67%
17.53%
11.02%
8.25%
9.48%
9.65%
12.82%
Gross Profit Margin
11.14%
7.54%
15.69%
14.88%
12.24%
18.33%
18.82%
PAT Margin
2.81%
2.04%
7.95%
4.22%
2.67%
7.62%
9.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -13.07% vs 7.97% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 20.06% vs -72.31% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -29.71% vs 44.00% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 25.00% vs -9.68% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Fuji Pharma Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
13,819.00
11,591.00
2,228.00
19.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
13,819.00
11,591.00
2,228.00
19.22%
Raw Material Cost
8,304.00
9,239.00
-935.00
-10.12%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
105.00
33.00
72.00
218.18%
Selling and Distribution Expenses
3,215.00
1,226.00
1,989.00
162.23%
Other Expenses
58.30
-3.30
61.60
1,866.67%
Total Expenditure (Excl Depreciation)
12,207.00
10,465.00
1,742.00
16.65%
Operating Profit (PBDIT) excl Other Income
1,612.00
1,126.00
486.00
43.16%
Other Income
70.00
343.00
-273.00
-79.59%
Operating Profit (PBDIT)
2,734.00
2,612.00
122.00
4.67%
Interest
105.00
33.00
72.00
218.18%
Exceptional Items
-1,089.00
0.00
-1,089.00
Gross Profit (PBDT)
5,515.00
2,352.00
3,163.00
134.48%
Depreciation
1,052.00
1,143.00
-91.00
-7.96%
Profit Before Tax
487.00
1,435.00
-948.00
-66.06%
Tax
99.00
386.00
-287.00
-74.35%
Provisions and contingencies
0
0
0.00
Profit After Tax
389.00
1,036.00
-647.00
-62.45%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
389.00
1,036.00
-647.00
-62.45%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
14.00
-14.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
389.00
1,050.00
-661.00
-62.95%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
51,359.00
52,262.00
-903.00
-1.73%
Earnings per share (EPS)
15.50
35.20
-19.70
-55.97%
Diluted Earnings per share
15.50
35.20
-19.70
-55.97%
Operating Profit Margin (Excl OI)
11.67%
9.71%
0.00
1.96%
Gross Profit Margin
11.14%
22.24%
0.00
-11.10%
PAT Margin
2.81%
8.94%
0.00
-6.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,381.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -13.07% vs 7.97% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 24.55% vs 4.26% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 38.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 20.06% vs -72.31% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 31.42% vs -80.50% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 266.40 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -29.71% vs 44.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 31.17% vs -17.20% in Mar 2025

Quarterly - Interest
Interest 10.50 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 25.00% vs -9.68% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 59.09% vs 53.49% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.67%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025